Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Burkitt Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma 16 Leukemia, Myeloid, Acute 16 Lymphoma, Follicular 15 Neoplasms 14 Lymphoma, Non-Hodgkin 14 Breast Neoplasms 12 Leukemia, Lymphocytic, Chronic, B-Cell 11 Recurrence 10 Hodgkin Disease 10 Myelodysplastic Syndromes 9 Melanoma 9 Ovarian Neoplasms 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Biphenotypic, Acute 7 Hematologic Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Pancreatic Neoplasms 6 Lymphoma, B-Cell 6 Leukemia 6 Sarcoma 5 Rhabdomyosarcoma 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Triple Negative Breast Neoplasms 4 Sarcoma, Ewing 4

Interventions

Dasatinib 2 ponatinib 1 pembrolizumab 1 nilotinib 1 decitabine and cedazuridine drug combination 1 Interviews as Topic 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡